Oct 272016
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– UK, London – Advanced Oncotherapy plc (AIM: AVO), the developer of next-generation proton therapy systems for cancer treatment, announces that Nicolas Serandour, Chief Operating Officer and Chief Financial Officer, will become Chief Executive Officer with immediate effect.… => Read more

Advanced Oncotherapy appoints Nicolas Serandour as CEO alongside Michael Sinclair as Executive Chairman

From:: Advanced Oncotherapy appoints Nicolas Serandour as CEO alongside Michael Sinclair as Executive Chairman

Sorry, the comment form is closed at this time.

%d bloggers like this: